On Tuesday, October 19th, 2021, the Pershing Square Sohn Cancer Research Alliance held its Fifth Annual Pershing Square Sohn Retreat at the Simons Foundation in Manhattan, New York.
The Retreat highlighted the 2018 Pershing Square Sohn Prize winners who had just finished their third and final year of funding. These seven bold and creative scientists presented their research supported by the Prize to their peers, with robust Q&A discussions with guests in attendance both in-person and virtually via Zoom. The day concluded with fireside chat with an accomplished leader in academia and industry, Michel Sadelain, MD, PhD, the Stephen and Barbara Friedman Chair and Director of the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center, as well as the Scientific Co-Founder of Juno Therapeutics and Member of PSSCRA’s Scientific Review Council. The Pershing Square Foundation President and Pershing Square Sohn Cancer Research Alliance Co-Founder and Executive Director Olivia Tournay Flatto, PhD moderated the discussion.